Specialty Pharmacy

With the groundbreaking advancements in specialty pharmacy, it is important to recognize the uniqueness of these medications and their respective patient populations.

Although transfering the annual event to a virtual format presented challenges, NASP President and CEO Sheila Arquette, RPh, said she is excited to connect with attendees just as much as in previous years.

Research may address the lack of effective treatments for mental fatigue among patients with multiple sclerosis.

This year’s annual NASP meeting will feature an enhanced virtual environment that allows attendees to earn required CPE credits, share best practices, and browse a convention hall.

Home infusion of teprotumumab-trbw (Tepezza), a breakthrough treatment for thyroid eye disease, was found to effectively minimize the chance of infection with coronavirus disease 2019 for both patients and staff of Chartwell Pennsylvania, LP.

In the United States, these findings would translate to more than 269,000 prevented breast cancer cases and nearly 44,000 prevented cases of ovarian cancer.

As more Americans identify as LGBTQIA+, an effort needs to made to educate pharmacists on LGBTQIA+ health and culture.

Representatives from the organizations spoke with HHS last week before President Donald Trump signed several executive orders, including one that would address manufacturer rebates also collected by PBMs.

Officials with the FDA have approved atezolizumab plus cobimetinib and vemurafenib for the treatment of patients with BRAF V600 mutation-positive advanced melanoma.

A new study found that it’s safe for patients with HIV to receive HIV-positive kidneys.

Although the treatment of cancer is facing many challenges, the pandemic is also creating massive amounts of new data with which to educate patients, conduct new research, and make more informed clinical decisions.

New research suggests vitamin D can help prevent colitis in those using immune checkpoint inhibitors.

Spinal muscular atrophy is the leading genetic cause of death in infants.

Earlier results of the FAST trial, which was launched in 2004, found that reducing the number of radiotherapy fractions to 5 was feasible and safe in the short term.

Patients with cancer diagnosed more than 24 months ago are at an increased risk of severe COVID-19.

Status reaffirms PTCE as the leader in continuing pharmacy education

In addition to its potential uses in cancer treatment, this novel drug delivery system could be used with magnetic resonance imaging or fluorescence imaging.

How a pharmacy performs with respect to specific measures can be associated with a DIR fee.

Pharmacists are central health care professionals in medication therapy management and play a crucial role in improving life quality outcomes among patients.

The International Society for Pharmaceutical Engineering (ISPE) released its newest guide to help pharmaceutical organizations achieve and maintain control in their critical utility systems.

Leung added that this is the first study to show the potential beneficial effects of ACE inhibitors and ARBs on colorectal cancer development, based on a large group of patients who were colorectal cancer-free at the beginning of the study.

The presence of ctDNA and CTCs in the plasma of the blood of women who have undergone chemotherapy prior to surgery for the treatment of triple-negative breast cancer (TNBC) are critical indicators in the prediction of disease recurrence and disease-free survival.

Mylan plans to launch adalimumab-fkjp in the United States in July 2023.

Since 2015, there has been an increase in the number of specialty pharmacies in the United States due to their potential of handling the complexities of cost and appropriate drug access and administration.

Tofersen proves safe in clinical trials in the treatment of amyotrophic lateral sclerosis.

Regardless of the channel through which a specialty medication is billed and filled, management strategies will be an essential cornerstone to controlling costs.

According to new research published in Clinical and Translational Immunology, a new cancer vaccine is ready for human trials following its success in preclinical studies.

Regular testing for hepatitis C virus has proven more effective than targeted testing.